Clinical trials
Terminated Phase 1 Bone Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
5 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2009 | 1 |
| 2012 | 1 |
| 2018 | 2 |
| 2022 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 5 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Duke University | 1 |
| Ipsen | 1 |
| M.D. Anderson Cancer Center | 1 |
| Merck Sharp & Dohme LLC | 1 |
| QSAM Therapeutics, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Bone Neoplasms | 5 |
| Sarcoma | 2 |
| Carcinoma, Renal Cell | 1 |
| Colorectal Neoplasms | 1 |
| Endocrine Gland Neoplasms | 1 |
| Melanoma | 1 |
| Mesothelioma, Malignant | 1 |
| Mouth Neoplasms | 1 |
| Neoplasm Metastasis | 1 |
| Neoplasms | 1 |
Trials
Showing 1 to 5 of 5. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.